On November 9, 2012, the Board of Directors of TG Therapeutics, Inc. appointed Yann Echelard to the Board pursuant to that certain common stock purchase agreement, dated as of January 30, 2012, as amended on May 11, May 21 and June 4, 2012, by and between the company and LFB. Dr. Echelard will serve as a director until his term expires at the 2013 annual meeting of stockholders, at which time he will stand for reelection by the company's stockholders. The company has not yet appointed Mr. Echelard to any Board committees.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 USD | +3.18% | -0.59% | -1.17% |
01/05 | Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts | MT |
01/05 | Transcript : TG Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.17% | 241.77Cr | |
+52.36% | 5.81TCr | |
-3.86% | 4.05TCr | |
+36.70% | 3.9TCr | |
-12.01% | 2.66TCr | |
+14.13% | 2.67TCr | |
-21.62% | 1.9TCr | |
+0.21% | 1.22TCr | |
+25.96% | 1.19TCr | |
+23.02% | 1.2TCr |
- Stock Market
- Equities
- TGTX Stock
- News TG Therapeutics, Inc.
- TG Therapeutics, Inc. Appoints Yann Echelard to Board